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Abstract
Objective-To analyse the relation between tar
and nicotine yield of cigarettes smoked in the recent
past and the risk ofmyocardial infarction.
Design-Multicentre case-control study con-
ducted between September 1988 and June 1989.
Setting-Over 80 coronary care units in various
Italian regions.
Subjects-916 patients with acute myocardial
infarction without history ofischaemic heart disease
and 1106 controls admitted to hospital for acute
conditions not related to known or suspected risk
factors for ischaemic heart disease.
Main outcome measures-Relative risk of myo-
cardial infarction according to type of cigarette
smoked adjusted for identified potential con-
founding factors. Brands of cigarettes classified
according to yield oftar and nicotine.
Results-Patients with acute myocardial infarc-
tion were more often smokers and among smokers
they tended to smoke more cigarettes. Compared
with non-smokers their estimated relative risks were
3 8, 4.3, 3*2, and 3-7 in the four categories oftar yield
(< 10, 10-15, > 15-20, and >20 mg, respectively). No
trend in risk across yields was evident when analysis
was restricted to smokers and allowance was made
for number of cigarettes. Compared with risks in
subjects in the lowest category of tar yield the
relative risks were 1-2, 0-8, and 1-0 for the subsequent
yields. Compared with risks in non-smokers the
relative risks ranged from 9 3 to 12 6 below the age of
50 but no trend was observed with increasing yield.
Conclusions-Changing to cigarettes with a lower
tar yield is not an effective means of reducing
tobacco related morbidity from myocardial infarc-
tion.
Introduction
There is definite evidence that smoking cigarettes
increases the risk of acute myocardial infarction and
other cardiovascular diseases.' In several developed
countries the concem about the health hazards of
cigarette smoking led many smokers to stop.2 Encour-
aged by the tobacco industry, many others have
changed to low tar and low nicotine cigarettes with the
hope that this would considerably reduce the health
risks associated with smoking.' There is in fact con-
sistent evidence that the risks of lung and other tobacco
related cancers are directly related to the tar yield of
cigarettes.3 4
Most deaths caused by smoking are, however, due to
cardiovascular disease,' and thus the relation between
risk of cardiovascular disease and cigarette yield is a
crucial issue in public health, but the evidence is scanty
and controversial.6' We analysed the relation between
cigarette yield and risk of acute myocardial infarction
by using data from a large Italian case-control study.
Subjects and methods
Our study was conducted between September 1988
and June 1989 in over 80 hospitals in various parts of
Italy that were participating in the second study of the
Gruppo Italiano per lo Studio della Sopravvivenza
nell'Infarto (GISSI-2), a randomised clinical trial of
alteplase v streptokinase and heparin v no heparin
for treating acute myocardial infarction in 12 490
subjects.'2 The design of this investigation has already
been described."3
In the present case-control investigation there were
916 subjects (801 men and 115 women, referred to as
cases) randomised to this second study who were
admitted to hospital for a confirmed episode of acute
myocardial infarction and with no history of ischaemic
heart disease. The median age was 57 (range 24-74)
years.
The controls were subjects admitted to the same
hospitals for acute conditions not related to known or
suspected risk factors of acute myocardial infarction.
Subjects with a history of coronary heart disease or
admitted for neoplastic, cardiovascular, or cerebro-
vascular disease or for any chronic condition were
specifically excluded from the comparison group.
A total of 1106 control subjects (976 men and
130 women) were interviewed. Of these, 487 were
admitted for traumatic conditions, 121 for non-
traumatic orthopaedic disorders, 277 for surgical
conditions, and 221 for other miscellaneous illnesses
such as ear, nose, throat, or dental disorders. Controls
were frequency matched to cases for age, sex, and
hospital. Their median age was 57 (range 23-74)
years. Fewer than 3% of all subjects approached (cases
and controls) refused to be interviewed.
A structured questionnaire including questions on
sociodemographic factors and lifestyle habits, diet,
coffee and alcohol consumption, physical activity,
history of selected conditions, and family history
of cardiovascular and cerebrovascular events was
administered to cases and controls by trained inter-
viewers. For 614 cases and 792 controls a measure of
serum cholesterol was also obtained.
Questions on smoking included smoking habit
(never, former, current), and for current and former
smokers the number of cigarettes or cigars or pipes
smoked a day, duration of smoking, history of the
brands of cigarettes used in the past and specifically in
the previous six months, and for former smokers time
since stopping. Subjects who had stopped smoking less
than two years before were considered as current
smokers.
Tar and nicotine yields of cigarettes sold in Italy are
published annually by the Ministry of Finances.'4 The
brands were classified according to their tar yield into
four categories: < 10 (low yield), 10- 15, > 15-20, and
over 20 mg (high yield). The lowest category included
most newer, vented filter cigarettes; the highest
category the oldest unfiltered ones; and the two
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intermediate categories other filtered cigarettes.
Though tar was used for the classification, the brands
were also classified according to their nicotine yield
with only few exceptions. The nicotine yield of the four
categories was, respectively, <0-6, 0-5-0-8, 0-8-1-3,
and 1-1-1-6 mg. No measure of carbon monoxide was
available.
STATISTICAL ANALYSIS
Relative risk of myocardial infarction and the corre-
sponding 95% confidence intervals for various cate-
gories of smokers compared with those who had
never smoked and within smokers were estimated by
multiple logistic regression models.'5 The variables
included in the models were sex, age (in five year
groups), education (three levels) serum cholesterol
concentration (tertiles plus one dummy variable for
missing values), history of diabetes and hypertension,
family history of acute myocardial infarction, body
mass index (three levels), and coffee consumption
(four levels). The significance of the linear trends in
risk was assessed by comparing the difference of the
deviances of the models with and without the relevant
term to the X2 distribution with one degree of freedom.
Results
The two groups were comparable in terms of sex
and age. Patients with myocardial infarction tended
to be more educated, had higher serum cholesterol
concentrations, more commonly had diabetes and
hypertension, more often had relatives with ischaemic
heart diseases, drank more coffee, and had higher body
mass indices.'3
Table I shows the distribution of subjects and
controls according to smoking habit and for current
smokers the number of cigarettes smoked daily, the
duration of smoking, and the corresponding relative
risks. Patients with acute myocardial infarction were
more often smokers and among smokers they tended to
smoke more cigarettes. Compared with non-smokers,
former smokers had a relative risk of 1-3, and the risk
for current smokers was 2-1 for smokers of fewer than
15 cigarettes a day, 3-1 for smokers of 15-24 cigarettes
a day, and 4-3 for smokers of 25 or more cigarettes a
day. No trend in risk was evident among categories of
duration, the risk being around 3 0 for all categories.
There was a significant interaction between smoking
and age (X2=20-08) p<001), the risk estimates being
substantially higher at younger ages. No significant
interaction was found with the other covariates
included in the models.
Table II presents the distribution of current smokers
and the corresponding estimated relative risks accord-
TABLE i-Distribution of 916 cases of acute myocardial infarction and
according to number ofcigarettes smoked and duration ofsmoking
ing to cigarette yield. Most smokers were in the third
category ofyield. Compared with those in non-smokers
the estimated risks were 3-8 in the lowest category and
4*3, 3-2, and 3-7 in the subsequent categories.
In table III the risks associated with various cigarette
yields are presented in current smokers only. In
both models allowance was made also for number of
cigarettes. When compared with those in subjects in
the lowest yield category the risk estimates were
1-2, 0-8, and 1 0 for the subsequent yields. Thus no
trend in risk with yield was observed.
Table IV presents the estimated relative risks of
current smokers of different yields of cigarettes relative
to non-smokers stratified for age. Below the age of 50
the relative risks ranged from 9-3 to 12-6, but no trend
with increasing yield was observed. No trend was
evident even above the age of 50, although the risk
estimates were considerably lower, ranging from 2-6 to
3-7.
Discussion
This case-control study on acute myocardial infarc-
tion conducted within the framework of the GISSI-2
clinical trial"2 further confirms the importance of
smoking as a cause of the disease, independently from
tar and nicotine yield of the last brand smoked. The
absence of major advantage by smoking low yield
cigarettes on the risk of acute myocardial infarction is
now unequivocally established.
The choice of hospital controls could be criticised as
smokers tend to be admitted to hospital more often
than non-smokers and tend to stay for longer periods.'6
This could lead to an over-representation of smokers
in the control group compared with the general
population and hence to an underestimation of the
relative risk of smoking. A major underestimation
would be surprising, however, as the risk estimates of
this study were among the highest reported to date.
Furthermore, we excluded from the comparison group
all patients with diagnoses known to be or potentially
related to smoking, and the smoking related risks were
comparable across major diagnostic categories of the
controls. Patients with acute myocardial infarction
lived long enough to be admitted to hospital and
interviewed; therefore, they do not represent all
patients with acute myocardial infarction. In this study
we could classify the most recent brand smoked
according to tar and nicotine but not yield of carbon
monoxide. Although the exact component of tobacco
associated with acute myocardial infarction has not
been defined' and carbon monoxide is not necessarily
correlated with tar and nicotine yields,'7-" the classifi-
cation produced is detailed enough to allow distinction
1106 controls, estimated relative nisks, and 95% confidence intervals
Relative risk (95% confidence interval)
Details of smoking habit No (%) of cases No (%) of controls Model 1* Model 2t
Never smoked 150 (16-4) 320 (28 9) 1 t 1 t
Former smokers 139 (15-2) 243(220) 1-4 (-0to 2-0) 1-3 (0-9 to 1-8)
Pipe or cigar smokers 3 (0-3) 9 (0-8) 0-8 (0-2 to 3 2) 0-8 (0-2 to 3-0)
No of cigarettes/day smoked by current smokers:
<15 111(121) 147(133) 19(1-4to27) 21(15to30)
15-24 262(286) 256(23-1) 2-9 (2-2 to 3-9) 3-1 (2-2 to 4-2)
>25 251 (274) 131 (11-8) 5-6(4-1 to 7-8) 43 (3-0 to 6-2)
X2 trend§ 121-4311 73 7811
Duration of smoking (years)¶:
<30 189 (206) 166 (15-0) 34 (2-3 to 49) 3 1 (20 to 4-6)
30-39 192 (21 0) 170 (15-4) 33 (2-4to46) 3-2 (2-2 to46)
340 243 (265) 197 (17-8) 30 (2-2 to 41) 2-9 (2-1 to 42)
*Estimates from multiple logistic regression models including tenns for sex, age, and education.
tEstimates from multiple logistic regression models including tenns for sex, age, education, cholesterol concentration, history of diabetes and hypertension,
family history of acute myocardial infarction, body mass index, and coffee consumption.
tReference category.
§Former smokers and pipe/cigar smokers excluded.
IIp<O-01.
¶Information missing for one control subject.
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TABLE II-Distribution of cases of acute myocardial infarction and controls, * estimated relative risks, and
95% confidence intervals according to the tar and nicotineyield ofbrand smoked duringpast six months
Relative risk (95% confidence interval)
Details of smoking habit Cases Controls Model lt Model 2*
Never smoked 150 320 1 1
Tar and nicotine yield for current smokers:
1 (< 10 mg tar, < 0.6 mg nicotine) 72 51 3-8 (2-4 to 5-8) 3-8 (2-3 to 6-1)
2 (< 10-15 mg tar, 0-5-0-8 mg nicotine) 103 57 4-6 (3-1 to 7 0) 4-3 (2-8 to 6-8)
3 (> 15-20 mg tar, 0-8 to 1-3 mg nicotine) 364 307 3-4 (2-5 to 4-5) 3 2 (2 3 to 4 3)
4(>20mgtar,1 1-1-6mgnicotine) 54 51 3-3 (21 to52) 3-7 (23to6-2)
Unknown 31 68
*Former smokers and pipe or cigar smokers excluded.
tEstimates from multiple logistic regression models including terms for sex, age, and education.
*Estimates from multiple logistic regression models including terms for sex, age, education, cholesterol
concentration, history of diabetes and hypertension, family history of acute myocardial infarction, body mass index,
and coffee consumption.
§Reference category.
TABLE iii-Estimated relative risks of acute myocardial infarction
and 95% confidence intervals among current cigarette smokers according
to tar and nicotineyield ofbrand smoked during past six months
Relative risk
(95% confidence interval)
Tar and nicotine yield Model 1* Model 2t
1 (<10 mg tar, < 0-6 mg nicotine) 1t it
2 (10-15 mgtar, 0 5-0-8 mgnicotine) 1-3 (0-8 to2-1) 1-2 (0-7 to 2-1)
3 (> 15-20 mg tar, 0-8-1-3 mg nicotine) 0 9 (0-6 to 1-4) 0-8 (0 5 to 1-3)
4 (>20mgtar, 1-1-1 6mgnicotine) 0-9 (05 to 1-6) 1-0(05 to 1-8)
*Estimates from multiple logistic regression models including terms for sex,
age, education, and number of cigarettes.
tEstimates from multiple logistic regression models including terms for sex,
age, education, number of cigarettes, cholesterol concentration, history of
diabetes and hypertension, family history of acute myocardial infarction,
body mass index and coffee consumption.
$Reference category.
TABLE Iv-Estimated relative risks * of acute myocardial infarction
and 95% confidence intervals for current cigarette smokers stratifiedfor
age according to tar and nicotine yield of brand smoked in past six
months
Age (years)
Details ofsmoking habit <50 >50
Never smoked lt lt
Tar and nicotine yield for current smokers:
1 (<lOmgtar, <0-6mgnicotine) 9-3(3-7to23-2) 3-1 (1-8to5-1)
2 (10-15 mg tar, 0-5-0-8 mg nicotine) 12 6 (5 3 to 29 8) 3-7 (2-3 to 6 0)
3 (> 15-20 mg tar, 0-8-1-3 mg nicotine) 9 6 (4 7 to 19-5) 2-6 (1 9 to 3 6)
4 (> 20 mg tar, 1 1-1-6 mg nicotine) 9 7 (3-4 to 27 6) 2-6 (1 5 to 4-3)
*Estimates from multiple logistic regression models adjusted for sex, age,
and education.
tReference category.
between newer low yield cigarettes and higher yield
ones in terms ofpublic health.
The risk of acute myocardial infarction was not
associated with duration of smoking, and former
smokers had a substantially lower risk than current
smokers.' Thus, the risk of acute myocardial infarction
was influenced principally, if not completely, by
smoking habit in the recent past, and therefore we used
for all analyses the yield of the brand smoked in the
previous six months. This might even explain the
higher risk estimates of this study compared with
several cohort studies in which assessment of smoking
habits was often made several years before the disease
developed and thus a greater misclassification among
categories of smoking is conceivable. We also ensured
the accurate definition of diagnosis for cases, a com-
parable setting of interview for cases and controls, and
the adequate allowance for quantity smoked and other
tobacco related variables. The response rate was par-
ticularly high.
Our results are consistent with those from two large
case-control studies from America based on 502 cases
of myocardial infarction in men aged 30548 and 910 in
women under 65." In both sexes the risk did not vary
according to the nicotine or carbon monoxide yield of
the cigarette. The results from some cohort studies are
also similar,79 but evidence from cohort studies is not
totally consistent. These studies were, however, based
on small numbers of cases'0 and could not provide
adequate information on covariates or on smoking in
the recent past before the episode of infarction.6
In conclusion, therefore, shifting to lower yield
cigarettes is not an effective means of reducing tobacco
related morbidity from myocardial infarction.
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Abstract
Objective-To ascertain the annual incidence of
diabetes requiring treatment with insulin in children
and adolescents aged 0-19 years in Dar es Salaam,
Tanzania, during a 10 year period from 1 January
1982 to 31 December 1991.
Design-Prospective registration at a major urban
hospital of all patients with newly diagnosed diabetes
who were resident in Dar es Salaam.
Setting-Muhimbili Medical Centre, Dar es
Salaam, Tanzania.
Patients-86 patients: 45 male, 41 female.
Results-The annual incidence of juvenile dia-
betes for both sexes was 1-5 per 100000 population
aged 0-19 years (95% confidence interval 1-3 to 1-7).
Incidence per 100 000 population per year increased
with age: 0-6 (0 0 to 0.13) in the age group 0-4 years,
0.5 (0.3 to 0'7) at 5-9 years, 2-2 (1.8 to 2 6) at 10-14
years, and 3-4 (2.9 to 3.9) at 15-19 years.
Conclusion-Juvenile diabetes mellitus is fairly
rare in sub-Saharan Africa. If environmental
factors such as infection and material deprivation
were important determinants of insulin dependent
diabetes in Africans, as they may be in Europeans,
much higher rates would have been expected unless
genetic factors possibly exert a protective role. The
eightfold greater incidence in African Americans
than in Tanzanians may be related to greater genetic
admixture in African Americans with people from
countries in Europe with a high incidence.
Introduction
The incidence of juvenile diabetes varies widely
throughout the world, with higher rates in white popu-
lations than in most other ethnic groups.2 Highest
rates have been reported in Finland and lowest rates in
China, Japan, and Korea. Incidences are also con-
sidered to decrease progressively from northem to
equatorial latitudes.2 Contrary to this trend a sur-
prisingly high prevalence of 0 95 per 1000 children
aged 7-14 years was found in Khartoum, Sudan.3
Incidences, however, were not reported, and to our
knowledge there are no published studies of incidence
from sub-Saharan Africa. We describe the incidence
and prevalence of known juvenile diabetes mellitus in
Dar es Salaam, Tanzania, based on registry data
collected prospectively over 10 years.
Patients and methods
Dar es Salaam is Tanzania's largest city with a
population of 1-5 million. Most citizens are of African
origin, but there are sizable minorities of Indian
Asians, Arabs, and people of mixed race. In June 1981
a registry of all patients of indigenous African origin
with newly diagnosed diabetes was begun in the
diabetic clinic of Muhimbili Medical Centre, the city's
largest government hospital. Most African patients
with diagnosed diabetes are seen in this hospital. This
study includes all such patients aged 19 years and
under and resident in Dar es Salaam who were
registered between 1 January 1982 and 31 December
199 1.4 All required insulin from the time of diagnosis.
To ensure completeness of ascertainment, doctors in
the city's two major non-governmental hospitals were
asked if they knew of any African patients with juvenile
diabetes who were not known to us. They did not. We
consider therefore that ascertainment of diagnosed
juvenile diabetes was as complete as possible.
In the calculation of incidence data from the 1978
and 1988 national censuses were used. The number of
children in age groups 0-4, 5-9, 10-14, and 15-19 years
were noted and the difference in population numbers
in each age group between 1978 and 1988 calculated.
From this the annual rate of increase in the population
was estimated and assumed to be the same each year.
We thus derived population figures for 1982 and 1991
and used the mean of these two figures as denominator.
The estimated mean numbers of subjects in the
age groups 0-4, 5-9, 10-14 and 15-19 years during the
years 1982 to 1991 were 158 272, 142 939, 129 719,
and 146 656, respectively (total 576 586). All 95%
confidence intervals for the incidences are based on the
Poisson distribution.
Results
During the 10 years of 1982-91 inclusive 86 children
and teenagers (45 males, 41 females) between the ages
of 0 and 19 years and resident in Dar es Salaam were
seen. Table I shows the number of patients seen in each
age group each year. Of the 86 patients, 63 were seen in
the first five years and 23 in the second five years. Only
one patient below the age of 5 years was seen during the
10 years. The average crude annual incidence of
diagnosed diabetes over the 10 year period for both
sexes aged 0 to 19 years was 1-5 per 100 000 population
(95% confidence interval 1-3 to 1-7). Incidence per
TABLE 1-Numbers ofpatients with newly diagnosed juvenile diabetes
seen between 1 January 1982 and 31 December 1991 in Dar es
Salaam, Tanzania
Age (years)
Year 04 59 10-14 15 19 0.19
1982 1 3 7 1 1
1983 2 9 1 1
1984 1 1 2 6 10
1985 4 5 9
1986 3 7 1 2 22
1987 2 2
1988 1 4 5
1989 1 3 4
1990 1 2 2 5
1991 1 4 2 7
Total 1 7 28 50 86
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